|
Mukhamadieva V.N., Shamsutdinova N.G., Abdulganieva D.I., Abdrakipov R.Z.,Mukhina R.G., Dyakova E.V., Sukhorukova E.V.
Peculiarities of COVID-19 clinical course in patients with various rheumatic diseases
|
№7 / 2023
|
|
Argunova A.N., Emelyanova E.A.
Experience of use of vaccination against pneumococcal infection (Prevenar 13) in patients with chronic non-specific diseases in the Republic of Sakha (Yakutia)
|
№6 / 2023
|
|
Malysheva V.A., Guryanova E.A., Tyurnikova S.R., Simunov Yu.L., Dmitrieva A.N., Peskov D.A., Vorontsov D.S.
Gender differences in patients after COVID pneumonia at the third stage of rehabilitation
|
№2 (приложение) / 2022
|
|
Yanushevich O.O., Levchenko O.V., Semenyakin I.V., Solodov A.A., Kebina A.L., Sycheva A.S., Grigorieva E.V., Pogosyan R.R.
Spontaneous pneumomediastinum in patients with COVID-19 pneumonia
|
№9 / 2021
|
|
Babak S.L., Gorbunova M.V., Malyavin A.G.
Strategy of mucolytic therapy: ambroxol
|
№1 / 2021
|
|
Zinnatullina A.R., Khamitov R.F.
Atypical complications with mild community-acquired pneumonia
|
№5 / 2019
|
|
A.S. Simbirtseva
Community-acquired pneumonia in patients with decompensated chronic heart failure
|
№2 / 2017
|
Русский
